Skip to content
healthcare.dev

EXPAREL

NDC 65250-133, bupivacaine, injection, suspension, liposomal, from Pacira Pharmaceuticals, Inc..

Product NDC
65250-133
Status
Listed
Labeler
Pacira Pharmaceuticals, Inc.
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INFILTRATION
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022496
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65250-133 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPIVACAINE13.3 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]

Package NDCNDC-11Package
65250-133-04652500133044 VIAL in 1 CARTON (65250-133-04) / 10 mL in 1 VIAL (65250-133-10)
65250-133-096525001330910 VIAL in 1 CARTON (65250-133-09) / 10 mL in 1 VIAL (65250-133-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bb5a9e59-0f51-11df-8a39-0800200c9a66
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65250-133

Use it

Look up 65250-133 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65250-133 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65250-133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.